Medication reconciliation is commonly organized around identifying discrepancies between medication lists and producing an accurate record at transitions of care. Yet a documented list may conceal disagreements about prescribing intent, medication supply, actual patient use, and responsibility for unresolved uncertainty. These disagreements become consequential when information moves between professionals and organizations with different knowledge, clinical authority, and opportunities for verification. This article develops a conceptual model of the medication list as a negotiated clinical record, drawing on contemporary evidence concerning medication reconciliation, information provenance, patient participation, electronic documentation, and interprofessional care transitions. Negotiation is defined as a clinically accountable process through which competing medication claims are interpreted, verified, revised, or retained as explicitly unresolved. The model distinguishes information contribution from prescribing authority, documentary agreement from clinical verification, and discrepancy detection from accountable resolution. It further proposes that unresolved discrepancies require identifiable responsibility, a specified next action, and continuity of that responsibility during handover. Source provenance, temporal relevance, professional decision rights, and patient knowledge are integrated as interacting conditions of record authority. The resulting account provides a basis for examining medication-information workflows without presuming that a single source is universally correct or that electronic consistency demonstrates safe medication use. Its contribution is conceptual and requires subsequent evaluation in different clinical and organizational settings.
